Search results
Found 6785 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections
General Research
20 January 2022
First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.
Attention and memory deficits persist for months after recovery from mild Covid
Coronavirus COVID-19 General Research
19 January 2022
Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.
Plaster cast or metal pins to treat a broken wrist? The results are in.
General Research
19 January 2022
An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.
New book expands the horizons of brain research
General Research
18 January 2022
A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.
New research sheds light on how ultrasound could be used to treat psychiatric disorders
General Research
14 January 2022
A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.
Dramatic fall in hospital admissions for child infections since start of Covid-19 pandemic
Coronavirus COVID-19 General Research
13 January 2022
Since the onset of the Covid-19 pandemic, there have been dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measures, school and workplace closures, and travel restrictions, finds a study published by The BMJ today.
Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry
General Research
11 January 2022
The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.
Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity
Awards and Appointments General
10 January 2022
Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.
New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread
General Research
5 January 2022
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.
New Year's Honours 2022
Awards and Appointments General
4 January 2022
Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2022.
Oxford team publish blueprint for making millions of doses of a new vaccine within 100 days
Coronavirus COVID-19 General
22 December 2021
The University of Oxford’s vaccine manufacturing research team has today published a pre-print paper demonstrating the feasibility of a step change in the speed and volume of production of adenovirus-vectored vaccines against new virus variants or other future pandemics.
Alan Davidson Foundation supports ground-breaking Motor Neurone Disease research
General Research
22 December 2021
A £210,000 donation from the Alan Davidson Foundation (ADF) has been made to the Nuffield Department of Clinical Neurosciences (NDCN) to advance the University’s world leading research into Motor Neurone Disease (MND). The funding will support a project manager for three years to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis and eventually, prevention of all forms of MND.
Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia
Coronavirus COVID-19 General Research
17 December 2021
A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.
New Oxford-Zeiss Centre of Excellence opens at the University of Oxford
General
17 December 2021
The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.
Many Long COVID patients continue to experience symptoms one year after hospital discharge
Coronavirus COVID-19 General Research
16 December 2021
People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge according to the latest results of a major national study.
Protein test could lead to earlier and better diagnosis of Parkinson’s
General Research
15 December 2021
Scientists at the Oxford Parkinson's Disease Centre (OPDC) have been able to use a highly-sensitive method called α-synuclein real-time quaking-induced conversion (αSyn-RT-QuIC) to observe the clumping of alpha-synuclein in the cerebrospinal fluid (CSF) taken from people with Parkinson’s. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson’s correctly in its early stages.
£50m funding for Poonawalla Vaccines Research Building at Oxford University
General
15 December 2021
The Poonawalla Vaccines Research Building is to be established at Oxford University following £50m funding commitment from Serum Life Sciences.
New resistance-busting antibiotic combination could extend the use of ‘last-resort’ antibiotics
General Research
14 December 2021
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant
Coronavirus COVID-19 General Research
13 December 2021
Researchers from the University of Oxford have analysed the impact of the Omicron COVID-19 variant of concern on one of the immune responses generated by vaccination.
RECOVERY Trial launches in South Africa
Clinical Trials Coronavirus COVID-19 General
13 December 2021
The world’s largest clinical trial investigating treatments for COVID-19 has now launched in South Africa, with the first patient recruited today. This is the fifth country to take part in RECOVERY, joining Nepal, Indonesia, Vietnam, and the United Kingdom.